Cryoport (CYRX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $16.84, -1.35% vs the prior close of $17.07.
- Volume 706.38K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CYRX dips 1.3% to $16.84. Closed at $16.84, -1.35% vs the prior close of $17.07. Day range $16.66–$17.14, opened at $17.05.
CYRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CYRX dips 1.3% to $16.84
- Closed at $16.84, -1.35% vs the prior close of $17.07. Day range $16.66–$17.14, opened at $17.05.
- Volume was 706.38K shares, 1.1x its 50-day average of 643.38K.
- Price is +2.4% vs its 50-day average ($16.44) and +30.3% vs its 200-day average ($12.92).
- 52-week range $7.61–$18.36; today's close sits at 86% of that range, 8.3% below the 52-week high.
Oct 15, 2026 — CYRX rises 2.6% to $17.07
- Closed at $17.07, +2.58% vs the prior close of $16.64. Day range $16.13–$17.13, opened at $16.49.
- Volume was 455.00K shares, 0.7x its 50-day average of 641.56K.
- Price is +4.1% vs its 50-day average ($16.40) and +32.5% vs its 200-day average ($12.89).
- 52-week range $7.61–$18.36; today's close sits at 88% of that range, 7.0% below the 52-week high.
Oct 14, 2026 — CYRX dips 1.8% to $16.64
- Closed at $16.64, -1.83% vs the prior close of $16.95. Day range $16.57–$17.16, opened at $16.75.
- Volume was 558.20K shares, 0.9x its 50-day average of 642.01K.
- Price is +1.7% vs its 50-day average ($16.36) and +29.5% vs its 200-day average ($12.85).
- 52-week range $7.61–$18.36; today's close sits at 84% of that range, 9.4% below the 52-week high.
Oct 13, 2026 — CYRX rises 0.7% to $16.95
- Closed at $16.95, +0.65% vs the prior close of $16.84. Day range $16.79–$17.14, opened at $17.11.
- Volume was 575.60K shares, 0.9x its 50-day average of 638.99K.
- Price is +3.8% vs its 50-day average ($16.34) and +32.3% vs its 200-day average ($12.81).
- 52-week range $7.61–$18.36; today's close sits at 87% of that range, 7.7% below the 52-week high.
Oct 12, 2026 — CYRX dips 2.9% to $16.84
- Closed at $16.84, -2.94% vs the prior close of $17.35. Day range $16.56–$17.28, opened at $17.22.
- Volume was 602.20K shares, 0.9x its 50-day average of 634.87K.
- Price is +3.3% vs its 50-day average ($16.31) and +31.8% vs its 200-day average ($12.78).
- 52-week range $7.61–$18.36; today's close sits at 86% of that range, 8.3% below the 52-week high.
Oct 9, 2026 — CYRX rises 2.7% to $17.35
- Closed at $17.35, +2.66% vs the prior close of $16.90. Day range $16.90–$17.66, opened at $16.90.
- Volume was 479.90K shares, 0.8x its 50-day average of 632.74K.
- Price is +6.6% vs its 50-day average ($16.27) and +36.2% vs its 200-day average ($12.74).
- 52-week range $7.61–$18.36; today's close sits at 91% of that range, 5.5% below the 52-week high.
Oct 8, 2026 — CYRX dips 2.6% to $16.90 on 1.9x normal volume
- Closed at $16.90, -2.59% vs the prior close of $17.35. Day range $16.65–$17.42, opened at $17.20.
- Volume was 1.21M shares, 1.9x its 50-day average of 619.73K — unusually heavy trading.
- Price is +4.1% vs its 50-day average ($16.23) and +33.0% vs its 200-day average ($12.70).
- 52-week range $7.61–$18.36; today's close sits at 86% of that range, 8.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CYRX dips 2.5% to $17.35 on 2.3x normal volume
- Closed at $17.35, -2.53% vs the prior close of $17.80. Day range $17.13–$17.55, opened at $17.36.
- Volume was 1.37M shares, 2.3x its 50-day average of 601.38K — unusually heavy trading.
- Price is +7.1% vs its 50-day average ($16.19) and +37.0% vs its 200-day average ($12.67).
- 52-week range $7.61–$18.36; today's close sits at 91% of that range, 5.5% below the 52-week high.
Oct 6, 2026 — CYRX dips 1.9% to $17.80 on 2.0x normal volume
- Closed at $17.80, -1.87% vs the prior close of $18.14. Day range $17.45–$18.36, opened at $18.36.
- Volume was 1.17M shares, 2.0x its 50-day average of 593.65K — unusually heavy trading.
- Price is +10.2% vs its 50-day average ($16.15) and +41.0% vs its 200-day average ($12.63).
- 52-week range $7.61–$18.36; today's close sits at 95% of that range, 3.1% below the 52-week high.
Oct 5, 2026 — CYRX jumps 4.1% to $18.14, a 52-week high on 1.8x normal volume
- Closed at $18.14, +4.07% vs the prior close of $17.43. Day range $17.30–$18.24, opened at $17.30.
- Volume was 1.05M shares, 1.8x its 50-day average of 584.35K — unusually heavy trading.
- Price is +12.7% vs its 50-day average ($16.10) and +44.1% vs its 200-day average ($12.59).
- 52-week range $7.61–$18.24; today's close sits at 99% of that range, 0.5% below the 52-week high.
Oct 2, 2026 — CYRX rises 0.4% to $17.43
- Closed at $17.43, +0.40% vs the prior close of $17.36. Day range $17.36–$18.06, opened at $17.57.
- Volume was 709.90K shares, 1.2x its 50-day average of 586.14K.
- Price is +8.7% vs its 50-day average ($16.04) and +39.0% vs its 200-day average ($12.54).
- 52-week range $7.61–$18.06; today's close sits at 94% of that range, 3.5% below the 52-week high.
CYRX latest news & SEC filings
Every SEC filing by or about CYRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Shelton Jerrell sold 28,800 shares at $14.91 (≈$429.41K) on Aug 11, 2026
- Shelton Jerrell sold 28,800 shares at $14.91 (≈$429.41K) on Aug 11, 2026
- Shelton Jerrell sold 28,800 shares at $14.91 (≈$429.41K) on Aug 11, 2026
- Shelton Jerrell sold 28,800 shares at $14.91 (≈$429.41K) on Aug 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $48.97M (prior year $45.45M) (+7.7% vs Jun 30, 2025)
- Net income: -$8.26M (prior year $108.87M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.20 (prior year $2.13) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 22, 2026 · Form 15-12G — Notice to deregister securities
Notice to deregister securities
Things to know before you trade CYRX
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Mar 3, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.48% (largest 4.1%).
- Liquidity: about 775.33K shares (≈$13.06M) trade per day on average.
- 52-week position: $16.84 vs a range of $7.61–$18.36 (86% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Jerrell Shelton sold 28,800 shares on Aug 11, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K Jun 9, 2026.
- Share count: 50.65M shares outstanding (Jul 31, 2026), +1.2% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CYRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 17.05 | 17.14 | 16.66 | 16.84 | 706.38K |
| Oct 15, 2026 | 16.49 | 17.13 | 16.13 | 17.07 | 455.00K |
| Oct 14, 2026 | 16.75 | 17.16 | 16.57 | 16.64 | 558.20K |
| Oct 13, 2026 | 17.11 | 17.14 | 16.79 | 16.95 | 575.60K |
| Oct 12, 2026 | 17.22 | 17.28 | 16.56 | 16.84 | 602.20K |
| Oct 9, 2026 | 16.90 | 17.66 | 16.90 | 17.35 | 479.90K |
| Oct 8, 2026 | 17.20 | 17.42 | 16.65 | 16.90 | 1.21M |
| Oct 7, 2026 | 17.36 | 17.55 | 17.13 | 17.35 | 1.37M |
| Oct 6, 2026 | 18.36 | 18.36 | 17.45 | 17.80 | 1.17M |
| Oct 5, 2026 | 17.30 | 18.24 | 17.30 | 18.14 | 1.05M |
| Oct 2, 2026 | 17.57 | 18.06 | 17.36 | 17.43 | 709.90K |
| Oct 1, 2026 | 17.40 | 17.53 | 17.00 | 17.36 | 1.04M |
| Sep 30, 2026 | 17.38 | 17.59 | 17.25 | 17.40 | 571.60K |
| Sep 29, 2026 | 17.38 | 17.55 | 17.06 | 17.32 | 931.70K |
| Sep 28, 2026 | 17.29 | 17.56 | 17.11 | 17.38 | 732.40K |
| Sep 25, 2026 | 17.36 | 17.59 | 17.22 | 17.41 | 729.90K |
| Sep 24, 2026 | 17.33 | 17.98 | 17.25 | 17.40 | 694.80K |
| Sep 23, 2026 | 17.46 | 17.64 | 17.00 | 17.49 | 568.90K |
| Sep 22, 2026 | 17.79 | 17.85 | 17.40 | 17.57 | 588.00K |
| Sep 21, 2026 | 17.17 | 17.65 | 17.00 | 17.62 | 760.60K |
About Cryoport
Cryoport (CYRX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BRENTWOOD, TN. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1124524.
CYRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Linda Baddour | Director | Jun 9, 2026 |
| Daniel M Hancock | Director | Jun 8, 2026 |
| Robert J Hariri | Director | Jun 8, 2026 |
| Ramkumar Mandalam | Director | Jun 8, 2026 |
| Jerrell Shelton | President, CEO | Aug 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jerrell Shelton | President, CEO | Aug 11, 2026 |
| Robert Stefanovich | Chief Financial Officer | Jun 8, 2026 |
| Mark W Sawicki | Chief Scientific Officer | Mar 25, 2026 |
| Edward J Zecchini | Chief Digital and Tech Officer | Jun 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 11, 2026 | Jerrell Shelton | Sale | 28,800 | $14.91 |
| Aug 11, 2026 | Jerrell Shelton | Sale | 28,800 | $14.91 |
| Aug 11, 2026 | Jerrell Shelton | Sale | 28,800 | $14.91 |
| Aug 11, 2026 | Jerrell Shelton | Sale | 28,800 | $14.91 |
| Jun 11, 2026 | Edward J Zecchini | Sale | 33,600 | $14.47 |
| Jun 11, 2026 | Edward J Zecchini | Sale | 33,600 | $14.47 |
| Jun 11, 2026 | Edward J Zecchini | Sale | 33,600 | $14.47 |
| Jun 11, 2026 | Edward J Zecchini | Sale | 33,600 | $14.47 |
| Jun 10, 2026 | Edward J Zecchini | Sale | 1,400 | $15.23 |
| Jun 10, 2026 | Edward J Zecchini | Sale | 1,400 | $15.23 |
| Jun 10, 2026 | Edward J Zecchini | Sale | 1,400 | $15.23 |
| Jun 10, 2026 | Edward J Zecchini | Sale | 1,400 | $15.23 |
| Jun 8, 2026 | Ramkumar Mandalam | Sale | 23,214 | $15.44 |
| Jun 8, 2026 | Ramkumar Mandalam | Sale | 23,214 | $15.44 |
| Jun 8, 2026 | Ramkumar Mandalam | Sale | 23,214 | $15.44 |
CYRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $176.18M | $78.30M | 1.40 | $-8.58M |
| Dec 31, 2024 | $156.77M | $-114.76M | -2.49 | $-16.32M |
| Dec 31, 2023 | $168.66M | $-99.59M | -2.21 | $-757.00K |
| Dec 31, 2022 | $237.28M | $-37.33M | -0.93 | $-1.85M |
| Dec 31, 2021 | — | $-275.53M | -6.18 | $8.13M |
Latest balance sheet: total assets $756.20M, total liabilities $265.50M, cash $269.27M (as of Jun 30, 2026).
CYRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $14.71 |
| May 4, 2026 | 8-K Item 2.02 (results) | $10.21 |
| Mar 3, 2026 | 8-K Item 2.02 (results) | $8.49 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $9.22 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $8.75 |
| May 7, 2025 | 8-K Item 2.02 (results) | $5.66 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $5.06 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $8.02 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CYRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.